Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulation of class IA PI3Ks.

H Wu1, Y Yan, J M Backer

  • 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Biochemical Society Transactions
|March 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analogs of the antimicrobial peptide trichogin having opposite membrane properties.

European journal of biochemistry·2001
Same author

Estimate of the frequency of true incomplete exchanges in human lymphocytes exposed to 1 GeV/u Fe ions in vitro.

International journal of radiation biology·2001
Same author

Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.

Current biology : CB·2001
Same author

Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup.

Cancer·2001
Same author

Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Comparison of F ratios generated from interphase and metaphase chromosome damage induced by high doses of low- and high-LET radiation.

Radiation research·2000
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles

Class IA phosphoinositide 3-kinases (PI3Ks) are crucial for cellular responses. This study explores how SH2 domains in the p85 regulatory subunit modulate PI3K activity, offering insights into normal cell regulation and cancer.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Class IA phosphoinositide 3-kinases (PI3Ks) are key regulators of cellular processes, producing phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P(3)).
  • Activation pathways involve receptor tyrosine kinases, GTPases, and G-protein subunits.
  • Understanding PI3K regulation is vital, as mutations can lead to constitutive activation in cancer.

Purpose of the Study:

  • To review recent studies on the regulation of class I PI3Ks (p85/p110).
  • To focus on the specific role of Src homology 2 (SH2) domains within the p85 regulatory subunit.
  • To elucidate how SH2 domains influence PI3K enzymatic activity.

Main Methods:

  • Review of crystallographic, biochemical, and structural studies.

Related Experiment Videos

  • Analysis of regulatory mechanisms in normal and transformed cells.
  • Focus on the interaction between p85 regulatory and p110 catalytic subunits.

    • Main Results:

    • Recent studies provide new insights into PI3K regulation.
    • The role of SH2 domains in the p85 subunit is highlighted for modulating PI3K activity.
    • Understanding these mechanisms is crucial for distinguishing normal function from oncogenic activation.

    Conclusions:

    • Class IA PI3Ks are tightly regulated enzymes essential for cellular signaling.
    • The p85 subunit's SH2 domains play a critical role in controlling PI3K activity.
    • Insights into PI3K regulation can inform cancer therapy strategies.